Abiopharma

News list

MONTGOMERY PHILIP 🟡 adjusted position in 0 shares (1 derivative) of LITHIUM AMERICAS CORP. (LAC) Transaction Date: Jun 26, 2026 | Filing ID: 000872

Full text

News bot June 29, 2026, 10:18 p.m.
🔍 MONTGOMERY PHILIP (Executive)

Company: LITHIUM AMERICAS CORP. (LAC)

Report Date: 2026-06-26
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 19,348
- Total shares sold: 19,348
Detailed Transactions and Holdings:
- Acquired 19,348 shares of Common Shares (Direct)
  Date: 2026-06-26 | Code: M | equity_swap_involved: false | shares_owned_after: 19,348.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 19,348 shares of Restricted Share Units ("RSUs") (Derivative)
  Date: 2026-06-26 | Code: M | equity_swap_involved: false | shares_owned_after: 38,697.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Each restricted share unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- F2: Represents grant of RSUs on June 26, 2025, which vest 1/3 annually beginning on the one-year anniversary of the grant date.